Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

237 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multiple-Ascending-Dose Phase 1 Clinical Study of the Safety, Tolerability, and Pharmacokinetics of CRS3123, a Narrow-Spectrum Agent with Minimal Disruption of Normal Gut Microbiota.
Lomeli BK, Galbraith H, Schettler J, Saviolakis GA, El-Amin W, Osborn B, Ravel J, Hazleton K, Lozupone CA, Evans RJ, Bell SJ, Ochsner UA, Jarvis TC, Baqar S, Janjic N. Lomeli BK, et al. Among authors: bell sj. Antimicrob Agents Chemother. 2019 Dec 20;64(1):e01395-19. doi: 10.1128/AAC.01395-19. Print 2019 Dec 20. Antimicrob Agents Chemother. 2019. PMID: 31685472 Free PMC article. Clinical Trial.
Safety, Tolerability, Systemic Exposure, and Metabolism of CRS3123, a Methionyl-tRNA Synthetase Inhibitor Developed for Treatment of Clostridium difficile, in a Phase 1 Study.
Nayak SU, Griffiss JM, Blumer J, O'Riordan MA, Gray W, McKenzie R, Jurao RA, An AT, Le M, Bell SJ, Ochsner UA, Jarvis TC, Janjic N, Zenilman JM. Nayak SU, et al. Among authors: bell sj. Antimicrob Agents Chemother. 2017 Jul 25;61(8):e02760-16. doi: 10.1128/AAC.02760-16. Print 2017 Aug. Antimicrob Agents Chemother. 2017. PMID: 28584140 Free PMC article. Clinical Trial.
Well controlled maternal inflammatory bowel disease does not increase the risk of abnormal neurocognitive outcome screening in offspring.
Prentice RE, Hunt RW, Spittle AJ, Ditchfield M, Chen J, Burns M, Flanagan EK, Wright E, Ross AL, Goldberg R, Bell SJ. Prentice RE, et al. Among authors: bell sj. Brain Behav Immun Health. 2024 Jul 22;40:100827. doi: 10.1016/j.bbih.2024.100827. eCollection 2024 Oct. Brain Behav Immun Health. 2024. PMID: 39149622 Free PMC article.
Prevalence and Impact of Unacceptable Symptom State among Patients with Psoriatic Arthritis: Results from the National Psoriasis Foundation's 2019 Annual Survey.
Zundell MP, Ogdie-Beatty AR, Perez-Chada L, Hamade H, Gondo GC, Khan AT, Bell SJ, Levy Z, Merola JF, Gottlieb AB. Zundell MP, et al. Among authors: bell sj. JID Innov. 2024 Jun 6;4(5):100292. doi: 10.1016/j.xjidi.2024.100292. eCollection 2024 Sep. JID Innov. 2024. PMID: 39149524 Free PMC article.
Vedolizumab and Ustekinumab Levels in Pregnant Women With Inflammatory Bowel Disease and Infants Exposed In Utero.
Prentice R, Flanagan E, Wright EK, Gibson PR, Rosella S, Rosella O, Begun J, An YK, Lawrance IC, Kamm MA, Sparrow M, Goldberg R, Prideaux L, Vogrin S, Kiburg KV, Ross AL, Burns M, Bell SJ. Prentice R, et al. Among authors: bell sj. Clin Gastroenterol Hepatol. 2025 Jan;23(1):124-133.e7. doi: 10.1016/j.cgh.2024.02.025. Epub 2024 Mar 15. Clin Gastroenterol Hepatol. 2025. PMID: 38492905
A plastic scintillator and HPGe β-γ coincidence detection system.
Goodwin MA, Gill TP, Davies AV, Britton R, Bell SJ, Regan PH. Goodwin MA, et al. Among authors: bell sj. Appl Radiat Isot. 2023 Nov;201:111028. doi: 10.1016/j.apradiso.2023.111028. Epub 2023 Sep 13. Appl Radiat Isot. 2023. PMID: 37748216
237 results